May 20, 2015
(Products confirming to the compendial specifications of USP, BP & Ph. EUR)
ExiPlus range of products has been specifically produced to meet the requirements of users working in the manufacture of drugs, active pharmaceutical ingredients, bio-pharmaceutical & neutraceutical products in semi-bulk or bulk scale.
The expansive range of ExiPlus products are manufactured in compliance with the reagent and monograph specifications (wherever applicable) of various pharmacopeia such as the United States Pharmacopeia (USP), British Pharmacopeia (BP) & European Pharmacopeia (Ph.Eur). Each product specifically mentions the compendial specifications complied to, making it easier for the user to make the
correct product selection.
Take the ExiPlus advantage,
- for use as an excipient
- for use as an active pharmaceutical ingredient
- for use in biopharmaceutical & vaccine production
- for use in neutraceutical & diagnostic production
- for use in critical research and development
The quality of our raw materials and our extensive documentation support enable quick, effective & cost-effective completion of projects. Ensuring a compendial
and complying parameters for the products, we ensure high level of consistency in QC, R&D and production applications. All necessary technical documents (Product Data Sheets, CoA, MoA) and other supporting
documentation can be made available upon request. Click to List ExiPlus Products ExiPlus, simplifying science.
|
